Clinical challenges and opportunities related to the biological responses experienced by indwelling and implantable bioelectronic medical devices
Source abstract
Abstract
Implantable electrodes have been utilized for decades to stimulate, sense, or monitor a broad range of biological processes, with examples ranging from glucose monitoring devices to cochlear implants. While the underlying science related to the application of electrodes is a mature field, preclinical and clinical studies have demonstrated that there are still significant challenges in vivo associated with a lack of control over tissue-material interfacial interactions, especially over longer time frames. Herein we discuss the current challenges and opportunities for implantable electrodes and the associated bioelectronic interfaces across the clinical landscape with a focus on emerging technologies and the obstacles of biofouling, microbial colonization, and the foreign body response. Overcoming these challenges is predicted to open the door for a new generation of implantable medical devices and significant associated clinical impact. STATEMENT OF SIGNIFICANCE: Implantable electrodes have been utilised for decades to stimulate, sense, or monitor a broad range of biological processes, with examples ranging from glucose monitoring devices to cochlear implants. Next-generation bioelectronic implantable medical devices promise an explosion of new applications that have until this point in time been impossible to achieve. However, there are several persistent biological challenges hindering the realisation of these new applications. We present a clinical perspective on how these biological challenges have shaped the device market and clinical trial landscape. Specifically, we present statistical breakdowns of current device applications and discuss biofouling, the foreign body response, and microbial colonisation as the main factors that need to be addressed before a new generation of devices can be explored.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neuroscience and Neural Engineering · Advanced Sensor and Energy Harvesting Materials · Muscle activation and electromyography studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. A brief history of cardiac pacing
2. Personal reflections on the multichannel cochlear implant and a view of the future10.1682/JRRD.2007.05.0064 ↗
3. ClinicalTrials.gov, https://clinicaltrials.gov/ (accessed September 21, 2022).
4. Web of Science Core Collection, https://www.webofscience.com/wos/woscc/advanced-search (accessed September 21, 2022).
5. BCC Research, 2022. Electroceuticals: technologies and global markets (No. MDS001B).
6. Biomedical Implants with Charge-Transfer Monitoring and Regulating Abilities
7. Investigating the electrical properties of different cochlear implants10.1097/MAO.0000000000002861 ↗
8. Reducing current spread using current focusing in cochlear implant users10.1016/j.heares.2011.12.009 ↗
9. Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators10.19102/icrm.2020.110207 ↗
10. Selection of stimulus parameters for deep brain stimulation10.1016/j.clinph.2004.05.031 ↗
11. High (130 Hz)- and mid (60 Hz)-frequency deep brain stimulation in the subthalamic nucleus differentially modulate response inhibition: a preliminary combined EEG and eye tracking study10.1016/j.nicl.2023.103314 ↗
12. Effect of exceeding compliance voltage on speech perception in cochlear implants10.1016/j.heares.2020.108112 ↗
13. Combining Place and Rate of Stimulation Improves Frequency Discrimination in Cochlear Implant Users10.1016/j.heares.2022.108583 ↗
14. Cardiac pacemakers: function, troubleshooting, and management: part 1 of a 2-part series10.1016/j.jacc.2016.10.061 ↗
15. StatPearls, StatPearls Publishing
16. Making post-mortem implantable cardioverter defibrillator explantation safe10.1093/europace/eup249 ↗
17. Strength-duration relationship for human transvenous defibrillation10.1161/01.CIR.96.10.3517 ↗
18. Cochlear implant material effects on inflammatory cell function and foreign body response10.1016/j.heares.2022.108597 ↗
19. Deep brain stimulation devices: a brief technical history and review10.1111/j.1525-1594.2008.00620.x ↗
20. Materials perspectives for self-powered cardiac implantable electronic devices toward clinical translation10.1021/accountsmr.1c00078 ↗
21. Current and emerging technology for continuous glucose monitoring10.3390/s17010182 ↗
22. US Food and Drug Administration, Center for Devices and Radiological Health, Eversense® E3 continuous glucose monitoring system P160048/S016 Approval Letter, February 10, 2022 [WWW Document]. URL https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160048S016A.pdf (accessed 12.22.22a).
23. Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable Eversense continuous glucose monitoring system: the PROMISE Study10.1089/dia.2021.0182 ↗
24. US Food and Drug Administration, Center for Devices and Radiological Health, n.d. Eversense continuous glucose monitoring system P160048 approval letter, June 21, 2018 [WWW Document]. URL https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160048A.pdf (accessed 12.22.22b).
25. Accuracy and longevity of an implantable continuous glucose censor in the PRECISE Study: a 180-day, prospective, multicenter, pivotal trial10.2337/dc16-1525 ↗
26. Interference assessment of various endogenous and exogenous substances on the performance of the eversense long-term implantable continuous glucose monitoring system10.1089/dia.2018.0028 ↗
27. Minimally invasive electrochemical continuous glucose monitoring sensors: recent progress and perspective10.1016/j.bios.2023.115103 ↗
28. Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: a post-market registry study10.1089/dia.2019.0159 ↗
29. Implementation of treatment protocols in the diabetes control and complications Trial10.2337/diacare.18.3.361 ↗
30. Current state of the art and future directions for implantable sensors in medical technology: clinical needs and engineering challenges10.1063/5.0152290 ↗
31. Continuous intra-arterial blood gas monitoring10.1007/BF01709527 ↗
32. A continuous, implantable lactate sensor10.1021/ac00105a010 ↗
33. Evaluation of continuous lactate monitoring systems within a heparinized in vivo porcine model intravenously and subcutaneously10.3390/bios8040122 ↗
34. Biosensors based on electrochemical lactate detection: a comprehensive review
35. Advances in the biosensors for lactate and pyruvate detection for medical applications: a review10.1016/j.trac.2018.11.004 ↗
36. Parylene-coated polytetrafluoroethylene-membrane-based portable urea sensor for real-time monitoring of urea in peritoneal dialysate10.3390/s19204560 ↗
37. Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis10.1038/nature16521 ↗
38. Biofuel-powered soft electronic skin with multiplexed and wireless sensing for human-machine interfaces10.1126/scirobotics.aaz7946 ↗
39. A laser-engraved wearable sensor for sensitive detection of uric acid and tyrosine in sweat10.1038/s41587-019-0321-x ↗
40. Electrochemical glucose biosensors10.1021/cr068123a ↗
41. Temporary epicardial pacing after cardiac surgery: a practical review10.1111/j.1365-2044.2007.04950.x ↗
42. Improved pacemaker pulse detection: clinical evaluation of a new high-bandwidth electrocardiographic system10.1016/j.jelectrocard.2010.09.008 ↗
43. Hunterian lecture on peritoneal adhesions
44. Control of innate immune response by biomaterial surface topography, energy, and stiffness10.1016/j.actbio.2021.04.021 ↗
45. T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response10.1016/j.actbio.2021.04.023 ↗
46. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
47. Nano- and microstructured materials for in vitro studies of the physiology of vascular cells10.3762/bjnano.7.155 ↗
48. The pathology of the foreign body reaction against biomaterials10.1002/jbm.a.35958 ↗
49. Biomaterials: foreign bodies or tuners for the immune response?10.3390/ijms20030636 ↗
50. Implant fibrosis and the underappreciated role of myofibroblasts in the foreign body reaction10.3390/cells10071794 ↗
51. Biomaterials: been there, done that, and evolving into the future10.1146/annurev-bioeng-062117-120940 ↗
52. Antifibrotic strategies for medical devices10.1016/j.addr.2020.06.008 ↗
53. Biocompatibility pathways: biomaterials-induced sterile inflammation, mechanotransduction, and principles of biocompatibility control10.1021/acsbiomaterials.6b00607 ↗
54. Macrophage and fibroblast interactions in biomaterial-mediated fibrosis10.1002/adhm.201801451 ↗
55. Impact of Protein Fouling on the Charge Injection Capacity, Impedance, and Effective Electrode Area of Platinum Electrodes for Bionic Devices10.1002/celc.202001574 ↗
56. Foreign body reaction to implanted biomaterials and its impact in nerve neuroprosthetics10.3389/fbioe.2021.622524 ↗
57. Electrical properties of implant encapsulation tissue10.1007/BF02368219 ↗
58. Flavopiridol reduces the impedance of neural prostheses in vivo without affecting recording quality10.1016/j.jneumeth.2009.06.026 ↗
59. Does Impedance Matter When Recording Spikes With Polytrodes?
60. C.M. Lewis, C. Boehler, R. Liljemalm, P. Fries, T. Stieglitz, M. Asplund, Recording Quality Is Systematically Related to Electrode Impedance, Adv. Healthc. Mater. n/a (n.d.) 2303401. https://doi.org/10.1002/adhm.202303401.10.1002/adhm.202303401 ↗
61. Impedance scaling for gold and platinum microelectrodes10.1088/1741-2552/ac20e5 ↗
62. Chronically implanted intracranial electrodes: tissue reaction and electrical changes10.3390/mi9090430 ↗
63. What is immune privilege (not)?10.1016/j.it.2006.11.004 ↗
64. Impedance changes and fibrous tissue growth after cochlear implantation are correlated and can be reduced using a dexamethasone eluting electrode10.1371/journal.pone.0147552 ↗
65. First-in-human testing of a wirelessly controlled drug delivery microchip10.1126/scitranslmed.3003276 ↗
66. Emerging rules for effective antimicrobial coatings10.1016/j.tibtech.2013.09.008 ↗
67. Treatment of infections associated with surgical implants10.1056/NEJMra035415 ↗
68. Leadless pacemakers reduce risk of device-related infection: review of the potential mechanisms10.1016/j.hrthm.2020.03.019 ↗
69. Device-associated infections: a macroproblem that starts with microadherence10.1086/323130 ↗
70. Seagrove Partners, Diabetes Bluebook, Seagrove Partn. LLC (n.d.). https://www.seagrovepartners.net/publications (accessed September 25, 2023).
71. Continuous glucose monitoring for diabetes: potential pitfalls for the general physician10.7861/CM-2022-0199.R1 ↗
72. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect10.1172/JCI111305 ↗
73. Combating implant infections: shifting focus from bacteria to host10.1002/adma.202002962 ↗
74. Hijacking of immune defences by biofilms: a multifront strategy10.1080/08927014.2019.1689964 ↗
75. Antifouling strategies for electrochemical biosensing: mechanisms and performance toward point of care based diagnostic applications10.1021/acssensors.1c00390 ↗
76. Implant infections: adhesion, biofilm formation and immune evasion10.1038/s41579-018-0019-y ↗
77. Amperometric enzyme electrode biofouling and passivation in blood: characterisation of working electrode polarisation and inner membrane effects10.1039/ft9938902847 ↗
78. The foreign body response demystified10.1021/acsbiomaterials.8b00252 ↗
79. Physicochemical principles of tissue material interactions10.1016/S1389-0344(02)00009-6 ↗
80. Effects of Sterilization on Implant Mechanical Property and Biocompatibility10.1177/039139880502801110 ↗
81. Sterilization of implantable polymer-based medical devices: a review10.1016/j.ijpharm.2017.12.003 ↗
82. 3.1.4 - Sterilization and disinfection of biomaterials for medical devices10.1016/B978-0-12-816137-1.00091-X ↗
83. Autoclave sterilization of PEDOT:PSS electrophysiology devices10.1002/adhm.201600870 ↗
84. Effective gamma-ray sterilization and characterization of conductive polypyrrole biomaterials10.1038/s41598-018-22066-6 ↗
85. Catechol-conjugated dextran for marine antifouling applications: the adverse effects of high catechol content10.1002/bkcs.12111 ↗
86. Inhibition of protein and cell attachment on materials generated from N-(2-hydroxypropyl) acrylamide10.1021/bm500654q ↗
87. Photo-crosslinked coatings based on 2-hydroxypropyl acrylamide for the prevention of biofouling10.1039/C9TB00044E ↗
88. A biomimetic alternative to poly(ethylene glycol) as an antifouling coating: resistance to nonspecific protein adsorption of poly(l-lysine)-graft-dextran10.1021/la800947z ↗
89. Tethering zwitterionic polymer coatings to mediated glucose biosensor enzyme electrodes can decrease sensor foreign body response yet retain sensor sensitivity to glucose10.1016/j.bios.2022.114815 ↗
90. Antifouling zwitterionic coating via electrochemically mediated atom transfer radical polymerization on enzyme-based glucose sensors for long-time stability in 37 °c serum10.1021/acs.langmuir.6b03016 ↗
91. Low-fouling nanoporous conductive polymer-coated microelectrode for in vivo monitoring of dopamine in the rat brain10.1021/acs.analchem.9b02386 ↗
92. Cross-linked antifouling polysaccharide hydrogel coating as extracellular matrix mimics for wound healing10.1039/C6TB03222B ↗
93. Biohybrid cochlear implants in human neurosensory restoration10.1186/s13287-016-0408-y ↗
94. Sensing conductive hydrogels for rapid detection of cytokines in blood10.1002/adhm.201500571 ↗
95. Conjugated polymers in bioelectronics: addressing the interface challenge10.1002/adhm.201900053 ↗
96. Zwitterionic phenyl layers: finally, stable, anti-biofouling coatings that do not passivate electrodes10.1021/am400519m ↗
97. Improvement of the biocompatibility and potential stability of chronically implanted electrodes incorporating coating cell membranes10.1021/acsami.8b20542 ↗
98. Distinctions and correspondences among surfaces contacting blood10.1111/j.1749-6632.1987.tb33041.x ↗
99. A survey of structure-property relationships of surfaces that resist the adsorption of protein10.1021/la010384m ↗
100. On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s10.1016/j.biomaterials.2014.02.029 ↗